Baxter Revenue 2006-2020 | BAX

Baxter annual/quarterly revenue history and growth rate from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Baxter revenue for the quarter ending June 30, 2020 was $2.718B, a 4.09% decline year-over-year.
  • Baxter revenue for the twelve months ending June 30, 2020 was $11.410B, a 3.24% increase year-over-year.
  • Baxter annual revenue for 2019 was $11.362B, a 2.37% increase from 2018.
  • Baxter annual revenue for 2018 was $11.099B, a 4.87% increase from 2017.
  • Baxter annual revenue for 2017 was $10.584B, a 4.14% increase from 2016.
Baxter Annual Revenue
(Millions of US $)
2019 $11,362
2018 $11,099
2017 $10,584
2016 $10,163
2015 $9,968
2014 $10,719
2013 $9,413
2012 $13,936
2011 $13,893
2010 $12,843
2009 $12,562
2008 $12,348
2007 $11,263
2006 $10,378
2005 $9,849
Baxter Quarterly Revenue
(Millions of US $)
2020-06-30 $2,718
2020-03-31 $2,802
2019-12-31 $3,039
2019-09-30 $2,851
2019-06-30 $2,834
2019-03-31 $2,638
2018-12-31 $2,819
2018-09-30 $2,761
2018-06-30 $2,842
2018-03-31 $2,677
2017-12-31 $2,797
2017-09-30 $2,707
2017-06-30 $2,605
2017-03-31 $2,475
2016-12-31 $2,645
2016-09-30 $2,558
2016-06-30 $2,585
2016-03-31 $2,375
2015-12-31 $2,603
2015-09-30 $2,487
2015-06-30 $2,475
2015-03-31 $2,403
2014-12-31 $2,789
2014-09-30 $2,709
2014-06-30 $4,154
2014-03-31 $3,848
2013-12-31 $4,322
2013-09-30 $3,710
2013-06-30 $3,669
2013-03-31 $3,448
2012-12-31 $3,499
2012-09-30 $3,477
2012-06-30 $3,572
2012-03-31 $3,388
2011-12-31 $3,594
2011-09-30 $3,479
2011-06-30 $3,536
2011-03-31 $3,284
2010-12-31 $3,498
2010-09-30 $3,224
2010-06-30 $3,194
2010-03-31 $2,927
2009-12-31 $3,470
2009-09-30 $3,145
2009-06-30 $3,123
2009-03-31 $2,824
2008-12-31 $3,131
2008-09-30 $3,151
2008-06-30 $3,189
2008-03-31 $2,877
2007-12-31 $3,009
2007-09-30 $2,750
2007-06-30 $2,829
2007-03-31 $2,675
2006-12-31 $2,763
2006-09-30 $2,557
2006-06-30 $2,649
2006-03-31 $2,409
2005-12-31 $2,491
2005-09-30 $2,398
2005-06-30 $2,577
2005-03-31 $2,383
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $41.987B $11.362B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $175.389B 32.91
Medtronic (MDT) Ireland $135.096B 21.94
Stryker (SYK) United States $70.813B 27.46
Boston Scientific (BSX) United States $56.240B 32.49
Lonza Group Ag (LZAGY) Switzerland $44.026B 0.00
Terumo (TRUMY) Japan $29.409B 37.59
Zimmer Biomet Holdings (ZBH) United States $28.616B 23.75
EssilorLuxottica Societe Anonyme (ESLOY) France $28.260B 0.00
ResMed (RMD) United States $25.025B 36.34
Sunny Optical Technology (SNPTF) China $20.071B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.905B 0.00
Bio-Rad Laboratories (BIO) United States $14.731B 66.62
Insulet (PODD) United States $13.054B 552.33
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.631B 51.02
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.229B 12.40
Hill-Rom Holdings (HRC) United States $6.398B 15.88
Canopy Growth (CGC) Canada $6.287B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.378B 0.00
Neogen (NEOG) United States $4.135B 69.09
Haemonetics (HAE) United States $4.050B 26.99
ICU Medical (ICUI) United States $4.048B 30.88
Envista Holdings (NVST) United States $3.688B 25.15
Abcam (ABCZY) $3.604B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.409B 0.00
National Vision Holdings (EYE) United States $2.831B 440.00
Agios Pharmaceuticals (AGIO) United States $2.792B 0.00
NuVasive (NUVA) United States $2.755B 38.40
DFB Healthcare Acquisitions (AHCO) United States $2.045B 188.38
TG Therapeutics (TGTX) United States $2.036B 0.00
AtriCure (ATRC) United States $1.843B 0.00
MacroGenics (MGNX) United States $1.447B 0.00
NanoString Technologies (NSTG) United States $1.356B 0.00
Aphria (APHA) Canada $1.281B 0.00
Aurora Cannabis (ACB) Canada $1.157B 0.00
Cerus (CERS) United States $1.138B 0.00
Cardiovascular Systems (CSII) United States $1.096B 0.00
InMode (INMD) Israel $0.995B 25.10
OraSure Technologies (OSUR) United States $0.960B 0.00
Quanterix (QTRX) United States $0.950B 0.00
Owens & Minor (OMI) United States $0.945B 21.17
Lantheus Holdings (LNTH) United States $0.914B 12.67
Omeros (OMER) United States $0.866B 0.00
PetIQ (PETQ) United States $0.832B 24.04
Phibro Animal Health (PAHC) United States $0.790B 15.76
Meridian Bioscience (VIVO) United States $0.750B 17.32
Vapotherm (VAPO) United States $0.742B 0.00
Surmodics (SRDX) United States $0.645B 70.73
VAREX IMAGING (VREX) United States $0.637B 15.81
BioLife Solutions (BLFS) United States $0.634B 330.33
Zynex (ZYXI) United States $0.623B 54.39
Eagle Pharmaceuticals (EGRX) United States $0.587B 82.92
LeMaitre Vascular (LMAT) United States $0.586B 35.79
Cytosorbents (CTSO) United States $0.401B 0.00
Viemed Healthcare (VMD) United States $0.399B 14.25
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.327B 0.00
Utah Medical Products (UTMD) $0.300B 25.71
InfuSystems Holdings (INFU) United States $0.258B 143.11
Organigram Holdings (OGI) Canada $0.234B 0.00
Female Health (VERU) United States $0.207B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Exagen (XGN) United States $0.181B 0.00
Bovie Medical (APYX) United States $0.178B 0.00
Fonar (FONR) United States $0.171B 15.14
Surface Oncology (SURF) United States $0.168B 0.00
Wound Management Technologies (SMTI) United States $0.167B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Evolus (EOLS) United States $0.126B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
Capricor Therapeutics (CAPR) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
United-Guardian (UG) United States $0.073B 16.35
Nephros (NEPH) United States $0.071B 0.00
Brainsway (BWAY) Israel $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
Akers Biosciences Inc (AKER) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00